Ying Sun

Ying Sun

Auto-generated profile, based on publicly available information

Ying Sun

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, Xi’an 710069, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Phytochemistry
Verified
Journal Article
Closed access
YBYajun Bai
Yajun Bai
YSYing Sun
Ying Sun
JXJing Xie
Jing Xie
BLBin Li
Bin Li
YBYujun Bai
Yujun Bai
XZXiaohui Zheng
Xiaohui Zheng

7 July 2020 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
YBYajun Bai
Yajun Bai
BLBin Li
Bin Li
JXJing Xie
Jing Xie
XCXufei Chen
Xufei Chen
SCShu Cheng
Shu Cheng
XZXiaohui Zheng
Xiaohui Zheng
Background: Our previous studies showed that α-asaronol was a potential antiepileptic candidate. Here, twelve O-terminus modified ester derivatives of α-asaronol were designed, synthesized and evaluated their anticonvulsant activity. Methods: All synthetic compounds were subjected to three animal models of seizure (MES, scPTZ and sc3-MP models) combined with neurotoxicity test, as well as the LDH inhibitory test. Furthermore, GABAA Receptor modulation and pharmacokinetic evaluation of compound 4k were also performed. Results: Five compounds (4a, 4b, 4d, 4e and 4k) showed significant anticonvulsant properties at the dose of 30-300 mg/kg in MES and scPTZ test, but weak activity in sc3-MP model. Meanwhile, 4a, 4b, 4d and 4k showed good LDH inhibitory activity in vitro. Specifically, 4k was the best compound in above evaluation, and better than that of α-asaronol and reference compound (stiripentol). In addition, 4k could increase chloride ion influx by modulating GABAA receptor α1β2γ2 subtype with EC50 of 48.65 ± 10.31 μM and showed good PK profiles in rats with moderate oral bioavailability (51.5%). Conclusion: These results suggested 4k possesses potential effectiveness in treatment of therapyresistant seizures and is expected to be developed as a novel molecule for safer and efficient anticonvulsants having neuroprotective effects as well as low toxicity.